Related Articles
Enhanced antitumor activity of trastuzumab emtansine (T-DM1) in combination with pertuzumab in a HER2-positive gastric cancer model
Lapatinib enhances trastuzumab-mediated antibody-dependent cellular cytotoxicity via upregulation of HER2 in malignant mesothelioma cells
Dual inhibition of IGF1R and ER enhances response to trastuzumab in HER2 positive breast cancer cells
Specific inhibitor of Notch‑3 enhances the sensitivity of NSCLC cells to gemcitabine
Berberine enhances gemcitabine‑induced cytotoxicity in bladder cancer by downregulating Rad51 expression through inactivating the PI3K/Akt pathway